Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Horm Behav. 2017 Nov 8;97:75–84. doi: 10.1016/j.yhbeh.2017.10.018

Table 2.

Statistical results and effect sizes for significant effects of hormone on behaviors and gene expression

Endpoint F- or Chi-squared values (degrees of freedom) for ANOVA or Mann-Whitney Eta-squared effect size p-value Directionality of effect t or z value Cohen’s d effect size p-value
USVS #FM calls: Interaction of trial x treatment at the 3-month testing period F(3, 90) = 4.56 η2 = 0.11 p < 0.05 VEH>E2 in Trial 2 t(30) = 5.67 d = 3.83 p < 0.05
Sociability Time immobile at the 3-month testing period V3>E3 z = −2.68 d = 0.77 p < 0.05
Distance traveled at the 3-month testing period E3>V3 z = −3.22 d = 1.04 p < 0.01
Speed at the 3-month testing period E3>V3 z = −2.98 d = 0.92 p < 0.05
Time near stimulus rat at the 6-month testing period For the V6 group, Cagemate>Novel z = −2.07 d = 1.08 p < 0.05
SON gene expression Drd2 X2(3,36) = 11.11 η2 = 0.32 p < 0.05 V6>V3/E3 z = −3.52 d = 1.37 p < 0.01
η2 = 0.14 E6>V3/E3 z = −2.32 d = 0.80 p < 0.05
lgf1 X2(3,35) = 11.40 η2 = 0.24 p < 0.05 V6>V3/E3 z = −3.03 d = 1.13 p < 0.05
η2 = 0.12 E6>V3/E3 z = −2.11 d = 0.73 p < 0.05
η2 = 0.14 V6>E3/V3 z = −2.34 d = 0.82 p < 0.05
PFC gene expression Oxtr F(3, 30) = 3.84 η2 = 0.28 p < 0.05 E6>V6 t= 2.809 d = 1.33 p < 0.05
Avpr1a F(3, 27) = 6.37 η2 = 0.42 p < 0.05 E6>V6 t= 2.899 d = 1.68 p < 0.05
E6>E3/V3 t= 2.845 d = 1.34 p < 0.05
Esr2 F(3, 30) = 5.58 η2 = 0.36 P < 0.05 E6>E3/V3 t= 3.269 d = 1.54 p < 0.05
Bdnf F(3, 30) = 3.76 η2 = 0.27 p < 0.05 V3/E3>V6 t= 2.795 d = 1.40 p < 0.05
V3/E3>E6 t= 1.981 d = 0.96 p < 0.05
E3/V3>V6 t= 3.032 d = 1.46 p < 0.05
E3/V3>E6 t= 2.098 d = 1.23 p < 0.05
PVN gene expression Oxtr F(3, 33) = 5.27 η2 = 0.32 p < 0.05 V3/E3>V6 t= 5.897 d = 2.89 p < 0.05
Tac3 F(3, 33) = 3.5 η2 = 0.24 p < 0.05 V3/E3>V6 t= 2.921 d = 1.38 p < 0.05
Oxt F(3, 33) = 5.27 η2 = 0.32 p < 0.05 E6>V6 t= 2.834 d = 1.32 p < 0.05
E6>V3/E3 t= 3.161 d = 1.51 p < 0.05
Pgr F(3, 34) = 6.57 η2 = 0.38 p < 0.05 V3/E3>V6 t= 4.337 d = 2.03 p < 0.05
V3/E3>E3/V3 t= 2.723 d = 1.25 p < 0.05
E6>V6 t= 3.287 d = 1.54 p < 0.05
Crh F(3, 30) = 6.28 η2 = 0.39 p < 0.05 V3/E3>V6 t= 3.241 d = 1.54 p < 0.05
V3/E3>E3/V3 t= 3.198 d = 1.60 p < 0.05
E6>V6 t= 2.888 d = 1.37 p < 0.05
Dnmt3a F(3, 33) = 3.19 η2 = 0.23 p < 0.05 E3/V3>V3/E3 t= 3.149 d = 1.45 p < 0.05
Egr1 F(3, 33) = 3.34 η2 = 0.23 p < 0.05 E3/V3>V6 t= 2.753 d = 1.28 p < 0.05
Ar X2(3,33) = 10.64 η2 = 0.12 p < 0.05 E6>V6 z = −2.12 d = 0.75 p < 0.05
η2 = 0.28 V3/E3>V6 z = −3.20 d = 1.23 p < 0.01
MeA gene expression Oxt X2(3,28) = 8.77 η2 = 0.32 p < 0.05 E3/V3>V6 z = −3.13 d = 1.36 p < 0.01
η2 = 0.14 E3/V3>V3/E3 z = −2.08 d = 0.81 p < 0.05
Avp F(3, 28) = 3.37 η2 = 0.27 p < 0.05 E3/V3>V6 t= 3.559 d = 1.95 p < 0.05
E3/V3>E6 t= 3.34 d = 1.88 p < 0.05
Ar X2(3,36) = 8.74 η2 = 0.29 p < 0.05 E3/V3>V6 z = −3.38 d = 1.29 p < 0.01
Drd1 X2(3,35) = 10.90 η2 = 0.22 p < 0.05 V6>V3/E3 z = −2.89 d = 1.06 p < 0.05
η2 =0.11 E6>V3/E3 z = −2.05 d = 0.71 p < 0.05
η2 = 0.20 E3/V3>V3/E3 z = −2.72 d = 0.98 p < 0.05
Drd2 F(3, 34) = 3.12 η2 = 0.22 p < 0.05 V6>V3/E3 t= 2.702 d = 1.16 p < 0.05
Htr2a X2(3,35) = 8.16 η2 = 0.22 p < 0.05 E3/V3>E6 z = −2.91 d = 1.07 p < 0.05
Oprd1 F(3, 34) = 5.55 η2 = 0.33 p < 0.05 V6>E6 t= 5.144 d = 2.52 p < 0.05
E3/V3>E6 t= 4.07 d = 1.90 p < 0.05
Gabbr1 F(3, 35) = 3.72 η2 = 0.24 p < 0.05 E6>V3/E3 t= 2.332 d = 1.02 p < 0.05
Grin2d X2(3,35) = 12.35 η2 = 0.18 p<0.01 V6>E6 z = −2.58 d = 0.92 p < 0.05
η2 = 0.19 V6>V3/E3 z = −2.71 d = 0.98 p < 0.05
Dnmt3a F(3, 34) = 9.29 η2 = 0.45 p<0.01 V6>V3/E3 t= 2.913 d = 1.27 p < 0.05
E3/V3>E6 t= 3.726 d = 1.83 p < 0.05
Nr3c1 X2(3,36) = 14.88 η2 = 0.28 p < 0.005 E3/V3>E6 z = −3.32 d = 1.25 p < 0.01
η2 = 0.20 E3/V3>V3/E3 z = −2.82 d = 1.01 p < 0.05
η2 = 0.12 V6>V3/E3 z = −2.20 d = 0.75 p < 0.05